• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • Global Health

    Nkengasong's bittersweet departure from Africa CDC

    Dr. John Nkengasong, the head of Africa CDC, is reportedly leaving the agency to lead PEPFAR. The agency will no doubt be "severely impacted" by this, but one person does not make an institution, says the co-chair of the AU’s Vaccine Delivery Alliance.

    By Sara Jerving // 22 September 2021
    Dr. John Nkengasong, director at the Africa Centres for Disease Control and Prevention. Photo by: Tiksa Negeri / Reuters

    United States President Joe Biden is reportedly nominating Dr. John Nkengasong, director of the Africa Centres for Disease Control and Prevention, to head the U.S. President’s Emergency Plan for AIDS Relief, a $7 billion operation. The U.S. government initiative has been without a permanent leader since February 2020. The Cameroonian virologist would be the first person from the African continent to head the program.

    Sign up for Devex CheckUp
    The must-read weekly newsletter for exclusive global health news and insider insights.

    This would be a homecoming, in one sense, for Nkengasong, who was one of the founding leaders of PEPFAR, which launched in 2003. He left the U.S. in 2016 when he was appointed to serve as the founding director of the Africa CDC.

    The New York Times reported the nomination late Tuesday, citing “several sources familiar with the matter,” saying Biden is expected to announce the nomination in the coming days.

    He would be taking the helm at PEPFAR during a critical time. A report out this week on the United Kingdom aid cuts said the "world is sleepwalking towards a new AIDS emergency and says that urgent action is needed to get the HIV response back on track."

    ‘An excellent choice’

    Many members of the health community rejoiced at the news.

    Winnie Byanyima, executive director of UNAIDS, tweeted: "Thrilled! An excellent choice. A long time leader in fighting #AIDS and great collaborator."  

    Mitchell Warren, executive director of the AIDS Vaccine Advocacy Coalition described Nkengasong as “someone who is accomplished and trusted in the global North and South” and “exactly what PEPFAR and the world need right now.”

    “We’re happy to see the world beginning to respond to decolonisation and the unequal balance of power in global leadership.”

    — Dr. Ayoade Olatunbosun-Alakija, co-chair, African Union’s African Vaccine Delivery Alliance

    “He is the connective tissue that can realize the needs of the people PEPFAR is meant to serve, with experience and action to accomplish the huge challenge ahead: to maintain the urgency and impact in ending the AIDS pandemic, to respond to COVID-19, and to build sustainable health infrastructure for the long-term," he said.

    PEPFAR has a tradition of meaningfully engaging with civil society, and this appointment is seen as a continuation of this collaboration, said Tian Johnson, founder of NGO African Alliance for HIV Prevention.

    A Devex conversation with Africa CDC's Dr. John Nkengasong

    Dr. John Nkengasong, director of the Africa Centres for Disease Control and Prevention, examines the challenges that lie ahead as the continent moves forward with the largest vaccination campaign in its history.

    "We will support him to gain a deeper and urgent appreciation of the critical role of Civil Society in the AIDS response and reflect on the many historical successes of PEPFAR that were achieved as a result of accountability, respect, and meaningful engagement with Civil Society," he said.

    At PEPFAR, Nkengasong would "no doubt bring his Africa experience to ensure greater equity and health justice for our continent and for all around the world," said Dr. Ayoade Olatunbosun-Alakija, co-chair of the African Union’s African Vaccine Delivery Alliance, in an email to Devex.

    She added that this appointment is strategic in that it addresses "agitation from so many of us for high level global health leadership positions for those from [low-income countries] who understand and can therefore navigate the complexities and unique challenges faced by those most in need from the Global South.”

    “We’re happy to see the world beginning to respond to decolonisation and the unequal balance of power in global leadership,” she said.

    A leader in responding to both HIV and COVID-19

    Nkengasong is an innovator in the field of HIV. In the 1990s, he built in Côte d'Ivoire, at the field station of the U.S. Centers for Disease Control and Prevention, one of the most sophisticated HIV labs in sub-Saharan Africa.

    This was one of the first laboratories in Africa to culture the HIV virus and to map out its genetic subtypes extensively. It also led to the efforts to start describing antimicrobial resistance to HIV treatment and examined strategies for reducing the transmission of HIV from mother to infant. Côte d'Ivoire was one of the first African nations to pilot the rollout of HIV drugs under his leadership.

    He then went on to work for PEPFAR, working to develop its laboratory program to strengthen laboratory capacity across Africa. His program was the largest and most funded program within the U.S. CDC’s HIV division.

    He left PEPFAR to serve as the founding director of Africa CDC. The agency rose to prominence during the pandemic as a highly trusted institution working to coordinate the continent’s COVID-19 response.

    This included bringing COVID-19 diagnostic tools to countries when there was none, setting up a network of labs to expand genomic sequencing, creating a pooled procurement platform for the purchase of vaccines, and deploying community health workers and other responders to countries in need.

    His leadership has earned him numerous accolades, such as making Time magazine’s list of the 100 most influential people of this year, which referred to him as a modern-day hero.

    Africa CDC’s fate

    While offering their congratulations to both Nkengasong and PEPFAR, some expressed concerns about the transition in leadership amid a pandemic. Nkengasong has been a tireless advocate for vaccine equity across the continent, which has fully vaccinated only less than 4% of the population.

    Peter Kamalingin, director of Oxfam International's Pan Africa Programme, told Devex this move would be great for Nkengasong, and PEPFAR is an important player in providing access to medicines across the African continent.

    "It would be unfair to place the fate of Africa CDC on John’s shoulders. He has set the agency on course and brought the visibility and profile needed to show that Africa CAN.”

    —  Dr. Ayoade Olatunbosun-Alakija, co-chair, African Union’s African Vaccine Delivery Alliance  

    But he said Nkengasong offered critical leadership not just on vaccine equity, but on the importance of investing in the long-term health security of countries across the continent. Kamalingin expressed concern that there could be a loss in momentum in these fights if Nkengasong leaves, as the African Union leadership works to replace him.

    “I think that it is going to be a challenge now, for us at this point in time, in the middle of the raging pandemic, for Africa — the stakeholders, the AU, and the member states to quickly, secure, strong leadership, a strong successor, not only to maintain, but actually to expand that momentum, that initiative, that leadership that Dr. Nkengasong was providing,” he said.

    Nkengasong’s leadership through these uncharted waters during the pandemic has been “very inspirational,” he said, adding that it will be important for the African Union to quickly find a successor with the important combination of skill sets that Nkengasong has — both technical capacity and passion.

    “He was shifting the conversation. He was rallying the continent and the member states,” he said. “As we celebrate the move of Dr. Nkengasong to PEPFAR, we must quickly make sure that we don't have a gap in leadership."

    While the Africa CDC will no doubt be "severely impacted" by Nkengasong's departure, one person does not make an institution, Olatunbosun-Alakija said.

    “This is a good day for Africa. It’s paradoxical but our loss is PEPFAR’s gain, and his promotion and recognition is past due,” she wrote to Devex.

    "It would be unfair to place the fate of Africa CDC on John’s shoulders. He has set the agency on course and brought the visibility and profile needed to show that Africa CAN," she said.  

    Updated: May 6, 2022: This article has been updated to reflect that PEPFAR has been without a permanent leader since February 2020.  

    More reading:

    ► The man behind Africa's COVID-19 response

    ► Africa CDC outlines ultracold storage strategy for COVID-19 vaccines

    ► Africa CDC official: Undelivered COVID-19 vaccine pledges 'not useful'

    • Global Health
    • Institutional Development
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Sara Jerving

      Sara Jervingsarajerving

      Sara Jerving is a Senior Reporter at Devex, where she covers global health. Her work has appeared in The New York Times, the Los Angeles Times, The Wall Street Journal, VICE News, and Bloomberg News among others. Sara holds a master's degree from Columbia University Graduate School of Journalism where she was a Lorana Sullivan fellow. She was a finalist for One World Media's Digital Media Award in 2021; a finalist for the Livingston Award for Young Journalists in 2018; and she was part of a VICE News Tonight on HBO team that received an Emmy nomination in 2018. She received the Philip Greer Memorial Award from Columbia University Graduate School of Journalism in 2014.

    Search for articles

    Related Stories

    Global healthAfrica CDC head said World Bank directed it to cut dozens of positions

    Africa CDC head said World Bank directed it to cut dozens of positions

    Global healthAfrican Union finally approves framework for Africa CDC epidemics fund

    African Union finally approves framework for Africa CDC epidemics fund

    Global healthTanzanian health expert is nominated to WHO's top Africa job

    Tanzanian health expert is nominated to WHO's top Africa job

    Devex CheckUpDevex CheckUp: WHO's emergencies czar is out — here's who's in

    Devex CheckUp: WHO's emergencies czar is out — here's who's in

    Most Read

    • 1
      Opinion: Mobile credit, savings, and insurance can drive financial health
    • 2
      How AI-powered citizen science can be a catalyst for the SDGs
    • 3
      Opinion: The missing piece in inclusive education
    • 4
      Opinion: India’s bold leadership in turning the tide for TB
    • 5
      How to support climate-resilient aquaculture in the Pacific and beyond
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement